Drane et al., 1994 - Google Patents
Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.Drane et al., 1994
- Document ID
- 1615481388707211938
- Author
- Drane W
- Abbott F
- Nicole M
- Mastin S
- Kuperus J
- Publication year
- Publication venue
- Radiology
External Links
Snippet
PURPOSE: At the time of the co-development of a commercial dual-headed gamma camera for whole-body single photon emission computed tomography (SPECT), modifications were made to permit imaging of 511-keV photons (from positron emitters) while maintaining …
- 238000002603 single-photon emission computed tomography 0 title abstract description 107
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
- G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
- G01T1/16—Measuring radiation intensity
- G01T1/161—Application in the field of nuclear medicine, e.g. in vivo counting
- G01T1/164—Scintigraphy
- G01T1/1641—Static instruments for imaging the distribution of radioactivity in one or two dimensions using one or several scintillating elements; Radio-isotope cameras
- G01T1/1648—Ancillary equipment for scintillation cameras, e.g. reference markers, devices for removing motion artifacts, calibration devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
- G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
- G01T1/29—Measurement performed on radiation beams, e.g. position or section of the beam; Measurement of spatial distribution of radiation
- G01T1/2914—Measurement of spatial distribution of radiation
- G01T1/2985—In depth localisation, e.g. using positron emitters; Tomographic imaging (longitudinal and transverse section imaging; apparatus for radiation diagnosis sequentially in different planes, steroscopic radiation diagnosis)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computerised tomographs
- A61B6/037—Emission tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computerised tomographs
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/50—Clinical applications
- A61B6/507—Clinical applications involving determination of haemodynamic parameters, e.g. perfusion CT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Drane et al. | Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress. | |
George et al. | Neuroactivation and Neuroimaging with SPET | |
Paans et al. | Positron emission tomography: the conceptual idea using a multidisciplinary approach | |
Bailey et al. | 68Ga PET ventilation and perfusion lung imaging—current status and future challenges | |
Ilem-Ozdemir et al. | Nuclear medicine and radiopharmaceuticals for molecular diagnosis | |
Zeltchan et al. | Study of potential utility of new radiopharmaceuticals based on technetium-99m labeled derivative of glucose | |
Brown et al. | Technical aspects of bone scintigraphy | |
Kaur et al. | Theranostics: New era in nuclear medicine and radiopharmaceuticals | |
Herzog | In vivo functional imaging with SPECT and PET | |
Gardner et al. | Principles and clinical applications of positron emission tomography | |
Da Silva et al. | Absolute in vivo quantitation of myocardial activity | |
Sabharwal et al. | Nuclear cardiology | |
WO2023007256A1 (en) | Improved dosing method for positron emission tomography imaging | |
Budzyńska et al. | PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and diagnostic activity levels: Anthropomorphic phantom study | |
Pathak | Use of radiation in diagnosis | |
Nekolla et al. | Preclinical Imaging of Cardiovascular Disesase | |
Shaikh | PET-CT imaging and applications | |
Townsend et al. | Application of Annihilation Coincidence Detection to Transaxial Reconstruction Tomography (perspective on “Application of Annihilation Coincidence Detection to Transaxial Reconstruction Tomography” J Nucl Med. 1975; 16: 210–224) | |
Tsui et al. | Whole-body scanning system for collection of quantitative in vivo distribution data in humans | |
Kelion et al. | Nuclear Cardiology | |
Giovanella et al. | Introduction to different pet radiopharmaceuticals and hybrid modalities (pet/ct and pet/mri) | |
Mantel et al. | Nuclear Medicine Technology | |
Chatachot | Evaluation of patient doses from 177lu-PSMA in metastases prostate cancer treatment at King Chulalongkorn Memorial hospital | |
Chu | Positron Emission Tomography-An Emerging Technology | |
Kissane et al. | Introduction to Nuclear Medicine |